Navigation Links
ACell and Medline Announce Exclusive Marketing and Distribution Agreement for MatriStem(TM) Proprietary Bioscaffold for Wound Care
Date:3/23/2009

COLUMBIA, Md. and MUNDELEIN, Ill., March 23 /PRNewswire/ -- ACell, Inc. and Medline Industries, Inc. jointly announced today that Medline has signed an exclusive marketing and distribution agreement for ACell's MatriStem(TM) Wound Care Matrix. Under the agreement, ACell will manufacture and Medline will market and distribute the products.

ACell's MatriStem regenerative medicine technology is a naturally occurring bioscaffold derived from porcine tissue. When MatriStem is placed onto a wound, it is resorbed and replaced with new native tissue where scar tissue would normally be expected. MatriStem devices, currently available in sheet and powder form, can be used in a broad range of medical applications such as wound care, general surgery, gastrointestinal surgery, urology and plastic and reconstructive surgery.

MatriStem Wound Care Matrix facilitates the healing process and is used on partial and full-thickness wounds such as diabetic, venous, arterial and pressure ulcers, and first and second-degree burns. The infected foot ulcer is the most common reason for hospitalization among patients with diabetes, resulting in over 200,000 days of inpatient care. Diabetes related amputations cost the health care system approximately $3 billion a year. Wound care devices, home health care and hospital costs associated with wound care, cost the U.S. healthcare system over $7 billion in 2007.

"As a well-established advanced wound care company, Medline will be an excellent partner for marketing and distributing our MatriStem Wound Care Matrix," stated Jim DeFrancesco, President and CEO of ACell, Inc. "We look forward to utilizing our unique regenerative medicine technologies in future collaborative efforts with Medline for creating additional advanced wound care products."

Jonathan Primer, President of Medline's Wound Care Division, commented, "We are pleased to announce our exclusive agree
'/>"/>

SOURCE ACell, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Seahorse XF96 Extracellular Flux Analyzer Wins Best New Product Award for DRUG DISCOVERY at 2009 Molecular Medicine Conference
2. Alfacell Announces Receipt of NASDAQ Panel Decision
3. Alfacell Announces Management Update
4. Alfacell Reports Financial Results for First Quarter of Fiscal 2009
5. Duracell and Actress Maggie Gyllenhaal Announce Winners of Power A Smile Casting Call After Nationwide Search for Five Child Holiday Ambassadors
6. SpectraCell Laboratories Expands Operations in New Facility
7. SpectraCell Laboratories Offers Additional Test for Heart Attack and Stroke Risk
8. Arthritis Foundation Grants Ease-Of-Use Commendation to Duracell EasyTab Hearing Aid Battery
9. Dr. Wei Sun, PhD, MD Joins SpectraCell Laboratories
10. Anti-Aging/Genetic Health Leader Suracell, Inc. Expands Internationally
11. Protein-dependent switch regulates intracellular trafficking in epithelial cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w
(Date:12/4/2009)STANFORD, Calif. A new study shows that muscle cells grown in the lab can restore an intestine,s ability to squeeze shut properly. The work, performed in dogs and rats, might ultimately help treat pa
(Date:12/4/2009)Rockville, MD "Why is it that men can be bastards and women must wear pearls and smile?" wrote author Lynn Hecht Schafran. The answer, according to an article in the Journal of Vision , may lie in
(Date:12/4/2009)Move a response to pressure from federal regulators to crack down on abuse of opioid medications , , FRIDAY, Dec. 4 (HealthDay News) -- The makers of 24 different prescription painkillers on F
Breaking Medicine News(10 mins):Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Are angry women more like men? 2Health News:Makers of Powerful Painkillers Present Safety Plans 2
...y researchers of St. Thomas’ Hospital, London, had...nit //of the hospital after cardiac surgery can in...e researchers had looked into the medical history ...r patients but who were discharged 48 hours after ...
...ave discovered a newer form of chicken pox vaccine...lled shingles. Shingles (also known as herpe...ashes or blisters on the skin, along with sensatio...ken pox and is caused by the same virus varicella-...
...has shown that nearly half of the patients in the ...experience delirium. Delirium is also one of the m...s. Delirium is a regular occurring condition ...ical costs for the patients and their families. ...
...ers who are constantly exposed to air pollutions o...air they inhale. Inhalation of polluted air o...us in womb. Pollutant particles emitted from the c...by National Institute of Environmental Health Scie...
...ave discovered that the use of the drug sargramost...nts of Crohn’s disease recover totally from their ...for treating cancer patients who are going through...ult to diagnose, as its symptoms are similar to ot...
...id that the problem of inability to read in dyslex...processes as was thought in recent years. Instead,...ems of perception than anything else. Dyslexi...ordination, concentration, perception, memory and ...
Other Medicine News:
(Date:12/4/2009)FREMONT, Calif., Dec. 4 Vermillion, Inc. (VRML) (Pink Sheets: VRMLQ) announced that on December 3, 2009, it filed its First Amended Plan of Reorganization and related amended Disclosure Statement wit
(Date:12/4/2009)DURHAM, N.C., Dec. 4 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced that the first patient has been enrolled in the company,s Phase II-b, dose escalation, clinical trial in S
(Date:12/4/2009)WASHINGTON, Dec. 4 Chemistry World recently highlighted a new report published by the Pharmaceutical Research and Manufacturers of America ( PhRMA ) that identifies 97 new drugs and vaccines in
Breaking Medicine Technology:Vermillion Files Amended Plan of Reorganization and Exchanges Debt 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 3Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Ohio Executive Shares Why Ohio is the Perfect Location for Bioscience Business in National Ad Campaign 14236 1Ohio Executive Shares Why Ohio is the Perfect Location for Bioscience Business in National Ad Campaign 14236 2Ohio Executive Shares Why Ohio is the Perfect Location for Bioscience Business in National Ad Campaign 14236 3CEL SCI Hires Clinical Research Organization for Clinical Study With Hospitalized H1N1 Infected Patients 5038 1CEL SCI Hires Clinical Research Organization for Clinical Study With Hospitalized H1N1 Infected Patients 5038 2CEL SCI Hires Clinical Research Organization for Clinical Study With Hospitalized H1N1 Infected Patients 5038 3CEL SCI Hires Clinical Research Organization for Clinical Study With Hospitalized H1N1 Infected Patients 5038 4Research team finds first evolutionary branching for bilateral animals 10060 1Research team finds first evolutionary branching for bilateral animals 10060 2
...pate and plan for various study outcomes, MEXICO ...(AVAC) today released a new report, Anticipating t...ction from governments, global health,institutions...r initial,results - expected as early as 2009 - fr...tested for HIV prevention, known as PrEP or,pre-ex...
...ctive Drug for Rare Genetic Disorder in,Children--...drug to achieve normal levels of blood sugar in an...gh insulin levels. If this approach,succeeds in hu...hildren,with congenital hyperinsulinism, a rare bu... insulin levels become dangerously high., "There ...
Other Medicine Technology:New AVAC Report on Pre-Exposure Prophylaxis Calls for Immediate Planning to Anticipate Study Results of Potential New HIV Prevention Option 2New AVAC Report on Pre-Exposure Prophylaxis Calls for Immediate Planning to Anticipate Study Results of Potential New HIV Prevention Option 3New AVAC Report on Pre-Exposure Prophylaxis Calls for Immediate Planning to Anticipate Study Results of Potential New HIV Prevention Option 4Treatment Corrects Severe Insulin Imbalance in Animal Studies 2Treatment Corrects Severe Insulin Imbalance in Animal Studies 3
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
Medicine Products: